Insider · CIK 0002016605
Denil Nanji Shekhat
Files at MIRA (MIRA PHARMACEUTICALS, INC.). First filing -, latest -.
In brief
Denil Nanji Shekhat files SEC Form 4 as director at MIRA (MIRA PHARMACEUTICALS, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Denil Nanji Shekhat has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 12, 2026 | MIRA MIRA PHARMACEUTICALS, INC. | AGrant or award Stock Options (right to buy)derivative | +50,000 | $0.00 | $0 | 50,000 | Jun 15, 2026 |
| Oct 1, 2025 | MIRA MIRA PHARMACEUTICALS, INC. | AGrant or award Common Stock | +22,378 | $1.35 | $30k | 22,378 | Oct 3, 2025 |
| Dec 9, 2024 | MIRA MIRA PHARMACEUTICALS, INC. | AGrant or award Stock Options (right to buy)derivative | +50,000 | $0.00 | $0 | 50,000 | Dec 10, 2024 |
Questions about Denil Nanji Shekhat
Answered from the filings on this page, as of the latest one.
Is Denil Nanji Shekhat buying or selling?
Denil Nanji Shekhat has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Denil Nanji Shekhat's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Denil Nanji Shekhat has 0.
Where does Denil Nanji Shekhat file Form 4?
Denil Nanji Shekhat has filed Form 4 at MIRA (MIRA PHARMACEUTICALS, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.